We are live on
!
Find out more
IGC Pharma
5 hedge funds and large institutions have $535K invested in IGC Pharma in 2013 Q2 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
+5
Holders Change %
–
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Wells Fargo
San Francisco,
California
| $470K | +$615K | +293,442 | New |
|
2
Morgan Stanley
New York
| $35K | +$46.7K | +22,294 | New |
|
|
KCG
3
Knight Capital Group
| $16K | +$21.9K | +10,449 | New |
|
4
Creative Planning
Overland Park,
Kansas
| $14K | +$18.9K | +9,035 | New |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| – | +$472 | +225 | New |
|
IGC Hedge Fund Activity: Q2 2013 in Review
5 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in IGC Pharma (IGC) for Q2 2013, worth a combined $535K.
Buyers outnumbered sellers: 5 funds opened new IGC positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.
- 5 institutional investors held IGC Pharma (IGC) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $535K of IGC Pharma stock for Q2 2013.
- 5 funds opened new IGC Pharma positions in Q2 2013 and 0 closed out, a net change of +5 holders.
Based on aggregated 13F filings for Q2 2013.